Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pruritus in Patients With Atopic Dermatitis”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Post-approval studies (Phase 4)Ended earlyNCT05200403
What this trial is testing

Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Boston University 72
Post-approval studies (Phase 4)Study completedNCT03388866
What this trial is testing

Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis

Who this might be right for
Atopic DermatitisEffects of Immunotherapy
Casa Espirita Terra de Ismael 91
Testing effectiveness (Phase 2)Ended earlyNCT03517566
What this trial is testing

Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 293
Post-approval studies (Phase 4)Study completedNCT04823130
What this trial is testing

Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 54
Not applicableUnknownNCT06488742
What this trial is testing

The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis

Who this might be right for
Dermatitis, AtopicPruritus
Nexgen Dermatologics, Inc. 60
Not applicableStudy completedNCT02238236
What this trial is testing

Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus

Who this might be right for
Rhinitis, Allergic, Perennial
Boehringer Ingelheim 3,793
Post-approval studies (Phase 4)UnknownNCT05265234
What this trial is testing

Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.

Who this might be right for
EczemaAtopic Dermatitis
OptiSkin Medical 15
Not applicableUnknownNCT05500794
What this trial is testing

Meditation in Inflammatory Dermatosis

Who this might be right for
Atopic DermatitisPsoriasisPruritus
Assistance Publique - Hôpitaux de Paris 72
Post-approval studies (Phase 4)Study completedNCT05590585
What this trial is testing

Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

Who this might be right for
Moderate-to-Severe Atopic DermatitisAtopic Eczema
Regeneron Pharmaceuticals 124
Not applicableLooking for participantsNCT07021495
What this trial is testing

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)+2 more
Leiden University Medical Center 840
Not applicableActive Not RecruitingNCT07017231
What this trial is testing

Role of Interleukin-13 Pathways on Pain and Itch Sensitivity ( IL-13 )

Who this might be right for
Itching
Aalborg University 26
Early research (Phase 1)Study completedNCT06787586
What this trial is testing

Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

Who this might be right for
Normal VolunteersAtopic Dermatitis (AD)Atopic Eczema+1 more
Attovia Therapeutics Inc 108
Post-approval studies (Phase 4)Study completedNCT00510003
What this trial is testing

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 117
Testing effectiveness (Phase 2)Study completedNCT00914186
What this trial is testing

Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)

Who this might be right for
Atopic Dermatitis
Taisho Pharmaceutical R&D Inc. 122
Large-scale testing (Phase 3)Study completedNCT03568331
What this trial is testing

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

Who this might be right for
Atopic Dermatitis
Vanda Pharmaceuticals 375
Large-scale testing (Phase 3)WithdrawnNCT05614817
What this trial is testing

CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Connect Biopharm LLC
Large-scale testing (Phase 3)Ended earlyNCT04140695
What this trial is testing

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)

Who this might be right for
Atopic Dermatitis
Vanda Pharmaceuticals 87
Testing effectiveness (Phase 2)Study completedNCT00838708
What this trial is testing

Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus

Who this might be right for
Pruritus, Atopic Dermatitis
Serentis Ltd. 62
Not applicableLooking for participantsNCT05790330
What this trial is testing

Mind and Skin - the Neurocutaneous Axis in Atopic Eczema

Who this might be right for
Atopic Dermatitis
King's College London 90
Testing effectiveness (Phase 2)Ended earlyNCT01605708
What this trial is testing

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Who this might be right for
PruritusAtopic Dermatitis
Regeneron Pharmaceuticals 19
Next Page